Skip to content

All recalls FDA

FDADrugsRecalled Status: Completed

STAQ Pharma, Inc. recalls ROPivacaine HCl 0.2% PF in Sodium Chloride 1

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Products
  • ROPivacaine HCl 0.2% PF in Sodium Chloride 1
Where it was sold

Nationwide within the United States

Nationwide

Units affected
2616 bags
About this recall
ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,